Skip to content
drillr.ai
Sign up

MIRM

Mirum Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$100.90
+0.27%
Ask drillr
0
Insider buys (3m)
22
Insider sells (3m)
-$13.9M
Net value (3m)
+8.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 3, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale21,688$99
Sep 3, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale8,312$98
Sep 3, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERM-Exempt30,000$2.94
Sep 3, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSale658$100
Aug 19, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERM-Exempt40,000$6.27
Aug 19, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSale40,000$100
Aug 12, 2026BJERKHOLT ERIC · officer: CHIEF FINANCIAL OFFICERSale6,001$100
Aug 11, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale2,300$100
Aug 11, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale11,683$99
Aug 11, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERM-Exempt20,000$2.94
Aug 11, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale6,017$99
Aug 5, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSale1,840$105
Jul 8, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale12,134$122
Jul 8, 2026BJERKHOLT ERIC · officer: CHIEF FINANCIAL OFFICERSale300$125
Jul 8, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale4,181$122
Jul 8, 2026BJERKHOLT ERIC · officer: CHIEF FINANCIAL OFFICERSale1,048$122
Jul 8, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERM-Exempt20,000$2.94
Jul 8, 2026BJERKHOLT ERIC · officer: CHIEF FINANCIAL OFFICERSale3,124$122
Jul 8, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale1,975$124
Jul 8, 2026BJERKHOLT ERIC · officer: CHIEF FINANCIAL OFFICERSale528$124
Jul 8, 2026Peetz Christopher · director, officer: CHIEF EXECUTIVE OFFICERSale1,710$125
Jul 2, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSale2,721$120
Jun 18, 2026Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSale2,594$102
Jun 17, 2026Cardon Lon · directorA-Award1,980$0.00
Jun 17, 2026Ramasastry Saira · directorA-Award3,772$101
Jun 17, 2026Walbert Timothy P · directorA-Award3,772$101
Jun 17, 2026Heron Patrick J · directorA-Award3,772$101
Jun 17, 2026Ramasastry Saira · directorA-Award1,980$0.00
Jun 17, 2026Fairey William · directorA-Award3,772$101
Jun 17, 2026Brege Laura · directorA-Award3,772$101
Institutional positioning

13F filings over the trailing two quarters

New 132Increased 245Reduced 192Sold out 42
FilerActionSharesFiled
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Increased7,679,684May 15, 2026
Frazier Life Sciences Management, L.P.Unchanged7,679,684Aug 14, 2026
JANUS HENDERSON GROUP PLCIncreased6,945,813May 18, 2026
Jupiter Topco LLCNew Position5,909,184Aug 14, 2026
BlackRock, Inc.Increased4,390,063Aug 7, 2026
BLACKROCK, INC.Increased3,846,530May 13, 2026
FMR LLCIncreased3,670,314Aug 13, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased2,655,607Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,414,776May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased2,377,019Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced2,254,109Aug 13, 2026
STATE STREET CORPIncreased2,170,689Aug 7, 2026
FMR LLCIncreased1,965,375May 15, 2026
STATE STREET CORPReduced1,944,281May 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased1,717,421May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026